UnitedHealth Group Incorporated Financial Ratios — UNH.DE

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	19.26	18.89	17.65	16.8	16.38	17.97	23.54	22.92	23.65	23.61	23.61	24.64	24.6	15.02	12.58
Return on Assets (%)	7.85	7.43	6.91	6.68	5.88	6	8.06	8.23	8.49	8.3	8.44	8.79	8.62	5.04	3.97
Return on Capital (%)	13.92	13.33	11.98	11.53	10.07	10.37	13.97	13.96	14.54	14.54	14.78	15.16	15.08	9.41	8.12
Return on Invested Capital (%)	13.83	13.24	12.27	11.84	10.71	11.03	15.08	15.38	16.04	15.82	16.25	16.84	16.95	14.47	9.25
Gross Margin (%)	24.69	25.19	24.44	25.3	23.57	23.47	23.37	23.8	23.79	26.06	24.22	24.56	24.48	22.33	18.53
EBITDA Margin (%)	9.41	9.55	8.98	9.01	8.09	8.11	8.68	8.74	9.25	9.84	9.41	9.82	9.78	9.09	5.21
Operating Margin (%)	8.31	8.37	7.86	7.87	7.01	7	7.56	7.67	8.13	8.71	8.33	8.77	8.71	8.07	4.24
Incremental Operating Margin (%)	7.79	9.02	3.11	8.15	2.8	6.88	13.97	8.51	14.72	18.15	5.14	12.21	8.27	-0.25	-28.17
Pretax Margin (%)	7.81	7.79	7.28	7.4	6.51	6.42	6.97	7.05	7.43	8.07	7.76	8.13	7.83	5.01	3.28
Profit Margin (%)	5.05	5	4.59	4.31	3.7	3.8	5.25	5.3	5.71	5.99	6.01	6.21	6.02	3.6	2.69
Net Income to Common Margin (%)	5.05	5	4.59	4.31	3.7	3.8	5.25	5.3	5.71	5.99	6.01	6.21	6.02	3.6	2.69
Effective Tax Rate (%)	35.39	35.91	36.37	41.81	42.64	40.38	22.82	22.34	20.81	23.98	20.52	21.65	20.5	24.06	12.86
Dvd Payout Ratio (%)	12.66	14.84	18.46	24.24	30.15	31.72	25.01	25.98	26.86	28.41	29.04	28.32	28.28	46.85	58.39
Sustainable Growth Rate (%)	16.82	16.09	14.39	12.73	11.44	12.27	17.65	16.96	17.3	16.9	16.75	17.66	17.64	7.98	5.24

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	11,638	16,754	16,860	17,406	31,965	32,970	31,692	36,554	40,678	43,467	46,003	57,623	62,537	76,904	78,389
ST Debt	982	2,713	1,969	1,399	6,634	7,193	2,857	1,973	3,870	4,819	3,620	3,110	4,274	4,545	6,069
LT Debt	10,656	14,041	14,891	16,007	25,331	25,777	28,835	34,581	36,808	38,648	42,383	54,513	58,263	72,359	72,320
Total Debt/EBITDA	1.21	1.59	1.53	1.48	2.51	2.2	1.82	1.85	1.82	1.72	1.7	1.81	1.72	2.11	3.36
Net Debt/EBITDA	0.23	0.79	0.87	0.84	1.66	1.5	1.13	1.3	1.33	1.05	0.91	1.08	1.02	1.42	2.32
Total Debt/EBIT	1.38	1.81	1.75	1.69	2.9	2.55	2.08	2.11	2.07	1.94	1.92	2.03	1.93	2.38	4.13
Net Debt/EBIT	0.26	0.9	1	0.96	1.91	1.74	1.3	1.48	1.51	1.18	1.03	1.2	1.15	1.6	2.85
EBITDA to Interest Expense	18.99	16.71	15.53	19.02	16.09	14.04	14.72	14.12	13.15	15.21	16.31	15.22	11.19	9.32	5.83
EBITDA-CapEx/Interest Expense	16.87	15.02	13.69	16.55	14.12	12.45	13.01	12.65	11.93	13.98	14.83	13.88	10.15	8.42	4.92
EBIT to Interest Expense	16.76	14.64	13.59	16.62	13.95	12.12	12.82	12.39	11.55	13.47	14.44	13.59	9.97	8.27	4.74
Interest Expense	505	632	708	618	790	1,067	1,186	1,400	1,704	1,663	1,660	2,092	3,246	3,906	4,002
Common Equity/Total Assets	40.99	37.92	40.37	39.18	33.38	33.35	35.05	36.69	35.19	35.13	36.35	35.07	34.99	32.2	30.88
Long-Term Debt/Equity (%)	37.66	42.17	44.69	47.3	71.43	64.14	55.43	61.5	59.21	54.79	55.42	63.13	58.9	70.53	71.11
Long-Term Debt/Capital (%)	27	28.34	29.15	30.41	35.81	33.99	34.05	35.67	34.59	32.8	33.15	35.78	34.58	39.57	39.83
Long-Term Debt/Total Assets (%)	15.7	17.36	18.19	18.53	22.77	20.99	20.74	22.72	21.17	19.59	19.97	22.19	21.29	24.26	23.36
Total Debt/Equity (%)	41.14	50.31	50.59	51.43	90.14	82.04	60.92	65.01	65.44	61.62	60.15	66.73	63.22	74.96	77.08
Total Debt/Capital (%)	29.49	33.81	33	33.07	45.19	43.47	37.43	37.71	38.23	36.89	35.98	37.82	37.12	42.05	43.17
Total Debt/Total Assets (%)	17.14	20.71	20.59	20.15	28.73	26.85	22.79	24.01	23.39	22.03	21.68	23.45	22.85	25.78	25.32
Net Debt to Equity	7.81	25.07	28.76	29.29	59.34	56.08	37.89	45.69	47.77	37.63	32.2	39.67	37.52	50.29	53.12
Net Debt/Capital (%)	7.35	20.29	21.87	21.95	35.18	34.46	27.11	29.84	31.12	26.31	23.13	26.56	25.94	32.74	34.36
EBITDA	9,588	10,563	10,998	11,752	12,714	14,985	17,454	19,772	22,405	25,296	27,073	31,835	36,330	36,386	23,325
EBITDA-CapEx	8,521	9,493	9,691	10,227	11,158	13,280	15,431	17,709	20,334	23,245	24,619	29,033	32,944	32,887	19,703
Operating Income (Loss)	8,464	9,254	9,623	10,274	11,021	12,930	15,209	17,344	19,685	22,405	23,970	28,435	32,358	32,287	18,964

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.5	0.42	0.33	0.3	0.3	0.27	0.31	0.27	0.23	0.27	0.31	0.31	0.3	0.28	0.24
Current Ratio	0.85	0.78	0.73	0.77	0.74	0.69	0.73	0.73	0.69	0.74	0.79	0.77	0.79	0.83	0.79
Quick Ratio	0.69	0.63	0.58	0.62	0.61	0.59	0.62	0.48	0.42	0.62	0.66	0.65	0.69	0.75	0.7
CFO/Avg Current Liab	0.29	0.28	0.25	0.28	0.26	0.21	0.27	0.3	0.32	0.33	0.3	0.31	0.31	0.24	0.18
Common Equity/Total Assets	40.99	37.92	40.37	39.18	33.38	33.35	35.05	36.69	35.19	35.13	36.35	35.07	34.99	32.2	30.88
Long-Term Debt/Equity (%)	37.66	42.17	44.69	47.3	71.43	64.14	55.43	61.5	59.21	54.79	55.42	63.13	58.9	70.53	71.11
Long-Term Debt/Capital (%)	27	28.34	29.15	30.41	35.81	33.99	34.05	35.67	34.59	32.8	33.15	35.78	34.58	39.57	39.83
Long-Term Debt/Total Assets (%)	15.7	17.36	18.19	18.53	22.77	20.99	20.74	22.72	21.17	19.59	19.97	22.19	21.29	24.26	23.36
Total Debt/Equity (%)	41.14	50.31	50.59	51.43	90.14	82.04	60.92	65.01	65.44	61.62	60.15	66.73	63.22	74.96	77.08
Total Debt/Capital (%)	29.49	33.81	33	33.07	45.19	43.47	37.43	37.71	38.23	36.89	35.98	37.82	37.12	42.05	43.17
Total Debt/Total Assets (%)	17.14	20.71	20.59	20.15	28.73	26.85	22.79	24.01	23.39	22.03	21.68	23.45	22.85	25.78	25.32
CFO/Total Liabilities	17.6	15.04	14.4	15.32	12.85	11.86	15.62	16.37	16.53	17.49	16.46	16.44	16.63	12.37	9.48
CFO/CapEx	6.53	6.69	5.35	5.28	6.26	5.74	6.72	7.62	8.92	10.81	9.1	9.35	8.58	6.92	5.44
Altman's Z-Score	4.66	4.48	4.67	5.2	4.88	5.11	5.49	5.26	5.3	5.08	5.71	5.59	5.47	5.1	4.3

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	46.78	44.22	42.52	35.73	29.16	25.19	22.7	21.59	20.87	20.83	21.24	20.33	19.08	18.34	19.72
Days Sales Outstanding	7.8	8.25	8.58	10.22	12.52	14.49	16.08	16.9	17.49	17.52	17.19	17.96	19.13	19.9	18.51
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	5.93	4.78	5	4.83	5.04	5.05	4.91	4.95	4.78	4.47	4.66	4.62	4.63	4.68	5
Accounts Payable Turnover Days	61.55	76.4	73	75.5	72.36	72.35	74.35	73.73	76.43	81.64	78.29	79.03	78.76	78.03	73.04
Cash Conversion Cycle	-53.74	-68.14	-64.42	-65.29	-59.84	-57.86	-58.28	-56.82	-58.94	-64.12	-61.1	-61.07	-59.63	-58.13	-54.53
Inventory to Cash Days	7.8	8.25	8.58	10.22	12.52	14.49	16.08	16.9	17.49	17.52	17.19	17.96	19.13	19.9	18.51
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	43,450	43,464	43,993	97,770	115,374	153,743	217,007	186,484	283,346	328,981	476,705	494,815	486,986	462,139	298,502
- Cash & Cash Equivalents	9,429	8,406	7,276	7,495	10,923	10,430	11,981	10,866	10,985	16,921	21,375	23,365	25,427	25,312	24,365
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	2,121	1,175	1,388	1,631	1,915	4,246	4,531	4,546	5,048	4,719	8,575	10,163	9,933	7,588
+ Total Debt	11,638	16,754	16,860	17,406	31,965	32,970	31,692	36,554	40,678	43,467	46,003	57,623	62,537	76,904	78,389
Enterprise Value	43,082	50,902	52,815	107,328	136,059	175,353	237,455	213,245	314,325	357,715	503,520	533,102	530,058	519,863	356,358
Total Capital	39,469	49,549	51,092	52,640	70,731	75,840	84,678	96,941	106,411	117,820	127,866	152,363	168,483	182,882	181,589
Total Debt/Capital (%)	29.49	33.81	33	33.07	45.19	43.47	37.43	37.71	38.23	36.89	35.98	37.82	37.12	42.05	43.17
Total Debt / EV	0.27	0.33	0.32	0.16	0.23	0.19	0.13	0.17	0.13	0.12	0.09	0.11	0.12	0.15	0.22
EV/Sales	0.42	0.46	0.43	0.82	0.87	0.95	1.18	0.94	1.3	1.39	1.75	1.64	1.43	1.3	0.8
EV/EBITDA	4.49	4.82	4.8	9.13	10.7	11.7	13.6	10.79	14.03	14.14	18.6	16.75	14.59	14.29	15.28
EV/EBIT	5.09	5.5	5.49	10.45	12.35	13.56	15.61	12.3	15.97	15.97	21.01	18.75	16.38	16.1	18.79
EV/Cash Flow to Firm	5.91	6.73	7.1	12.76	13.35	16.81	16.36	12.69	15.87	15.26	21.28	19.15	16.75	19.13	15.37
EV/Free Cash Flow to Firm	5.15	5.9	6.04	10.8	11.58	14.45	14.36	11.3	14.36	14.03	19.28	17.39	15.13	16.95	13.29
Diluted Market Cap	45,458	44,616	45,552	101,049	117,069	156,327	220,590	190,952	288,726	334,198	483,277	503,292	494,364	469,210	300,203
Diluted Enterprise Value	47,667	55,085	56,311	112,348	139,742	180,782	244,547	221,171	322,965	365,792	512,624	546,125	541,637	530,735	361,815
EV per Share	41.47	49.95	53.46	112.5	142.77	184.19	245.05	222.13	331.57	378.13	533.96	570.77	573.66	568.16	393.4
TTM Sales	101,862	110,618	122,489	130,474	157,107	184,840	201,159	226,247	242,155	257,141	287,597	324,162	371,622	400,278	447,567
TTM EBITDA	9,588	10,563	10,998	11,752	12,714	14,985	17,454	19,772	22,405	25,296	27,073	31,835	36,330	36,386	23,325
TTM Operating Income	8,464	9,254	9,623	10,274	11,021	12,930	15,209	17,344	19,685	22,405	23,970	28,435	32,358	32,287	18,964
TTM Cash Flow to Firm	7,294	7,560	7,442	8,411	10,193	10,431	14,511	16,800	19,812	23,438	23,662	27,845	31,649	27,170	23,184
TTM Free Cash Flow to Firm	8,361	8,630	8,749	9,936	11,749	12,136	16,534	18,863	21,883	25,489	26,116	30,647	35,035	30,669	26,806

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	5.66	5.42	5.49	10.55	10.36	13.59	14.12	10.74	14.06	13.8	19.49	17.35	15.23	16.94	12.87
EV/EBIT	5.09	5.5	5.49	10.45	12.35	13.56	15.61	12.3	15.97	15.97	21.01	18.75	16.38	16.1	18.79
Enterprise Value	43,082	50,902	52,815	107,328	136,059	175,353	237,455	213,245	314,325	357,715	503,520	533,102	530,058	519,863	356,358
Low Price	34.86	38.92	41.24	43.53	99.65	107.7	155.6	190.48	186.22	194.69	320.85	439.83	449	437.08	236.66
EV/Sales	0.42	0.46	0.43	0.82	0.87	0.95	1.18	0.94	1.3	1.39	1.75	1.64	1.43	1.3	0.8
EV/EBITDA	4.49	4.82	4.8	9.13	10.7	11.7	13.6	10.79	14.03	14.14	18.6	16.75	14.59	14.29	15.28
Price/Earnings	8.45	7.87	7.82	17.4	19.85	21.91	20.55	15.56	20.47	21.36	27.58	24.59	21.76	32.08	24.76
Price/Earnings Average	8.77	7.65	7.53	12.64	19.1	18.34	17.05	16.46	14.26	18.51	21.99	23.65	20.62	33.93	28.73
Price/Earnings High	10.07	8.01	7.82	17.86	21.21	22.58	21.32	20.06	20.71	22.79	27.77	26.08	22.95	39.96	45.24
Price/Earnings Low	7.04	7.18	7.24	7.39	16.34	14.61	14.28	15.26	12.76	11.96	17.5	20.42	18.54	27.76	17.78
Price/Book Value	1.56	1.42	1.33	2.89	3.11	3.75	4.45	3.34	4.63	4.75	6.18	5.74	5.08	4.81	3.12
Price/Book Value Average	1.62	1.38	1.28	2.1	2.99	3.14	3.69	3.53	3.23	4.11	4.93	5.52	4.82	5.09	3.62
Price/Book Value High	1.86	1.44	1.33	2.96	3.32	3.87	4.62	4.31	4.68	5.07	6.22	6.09	5.36	5.99	5.7
Price/Book Value Low	1.3	1.29	1.23	1.23	2.56	2.5	3.09	3.27	2.89	2.66	3.92	4.77	4.33	4.16	2.24
Price/Tangible Book Value	28.55	-16.28	-20.71	-35.33	-6.64	-9.65	-19.69	-15.53	-20.46	-28.23	-50.93	-23.12	-24.34	-16.86	-10.2
Price/Tangible Book Value Average	29.62	-15.83	-19.93	-25.66	-6.39	-8.08	-16.33	-16.43	-14.26	-24.46	-40.62	-22.23	-23.07	-17.83	-11.83
Price/Tangible Book Value High	34.03	-16.58	-20.72	-36.26	-7.09	-9.94	-20.42	-20.03	-20.7	-30.13	-51.29	-24.51	-25.67	-21	-18.63
Price/Tangible Book Value Low	23.8	-14.86	-19.18	-15.01	-5.46	-6.43	-13.68	-15.23	-12.75	-15.8	-32.33	-19.19	-20.74	-14.59	-7.32
Price/Sales	0.43	0.39	0.36	0.75	0.73	0.83	1.08	0.82	1.17	1.28	1.66	1.53	1.31	1.15	0.67
Price/Sales Average	0.44	0.38	0.35	0.54	0.71	0.7	0.89	0.87	0.82	1.11	1.32	1.47	1.24	1.22	0.77
Price/Sales High	0.51	0.4	0.36	0.77	0.78	0.86	1.12	1.06	1.18	1.37	1.67	1.62	1.38	1.44	1.22
Price/Sales Low	0.36	0.36	0.33	0.32	0.6	0.55	0.75	0.81	0.73	0.72	1.05	1.27	1.12	1	0.48
Price/Cash Flow	6.24	6.07	6.29	12.14	11.85	15.7	15.96	11.87	15.35	14.84	21.34	18.88	16.75	19.09	15.15
Price/Cash Flow Average	6.47	5.91	6.06	8.82	11.4	13.14	13.24	12.56	10.69	12.86	17.02	18.16	15.88	20.19	17.58
Price/Cash Flow High	7.43	6.18	6.29	12.46	12.66	16.18	16.56	15.31	15.52	15.83	21.49	20.02	17.67	23.78	27.69
Price/Cash Flow Low	5.2	5.54	5.83	5.16	9.75	10.47	11.09	11.64	9.56	8.31	13.54	15.68	14.27	16.52	10.88
Price/Free Cash Flow Average	5.87	5.27	5.28	7.66	9.97	11.38	11.72	11.37	9.8	11.95	15.54	16.69	14.44	17.91	14.94
Price/Free Cash Flow High	6.74	5.52	5.49	10.83	11.07	14.01	14.65	13.85	14.22	14.72	19.63	18.4	16.07	21.09	23.52
Price/Free Cash Flow Low	4.72	4.95	5.08	4.48	8.53	9.07	9.81	10.53	8.76	7.72	12.37	14.4	12.98	14.66	9.25
EV/Sales Average	0.46	0.48	0.43	0.63	0.85	0.83	1.01	1.01	0.96	1.23	1.42	1.6	1.37	1.37	0.91
EV/Sales High	0.53	0.49	0.45	0.86	0.93	0.99	1.24	1.2	1.33	1.49	1.77	1.75	1.51	1.59	1.36
EV/Sales Low	0.38	0.45	0.42	0.4	0.75	0.69	0.87	0.94	0.87	0.84	1.15	1.4	1.24	1.15	0.62
EV/EBITDA Average	4.93	4.99	4.83	7	10.51	10.22	11.69	11.51	10.34	12.52	15.13	16.29	14	15.12	17.49
EV/EBITDA High	5.63	5.18	4.98	9.5	11.48	12.21	14.27	13.69	14.32	15.13	18.82	17.83	15.44	17.51	26.02
EV/EBITDA Low	4.01	4.75	4.68	4.49	9.25	8.47	10.01	10.78	9.41	8.53	12.26	14.25	12.72	12.68	11.83
EV/EBIT Average	5.59	5.7	5.52	8.01	12.13	11.85	13.41	13.12	11.77	14.13	17.08	18.24	15.72	17.04	21.51
EV/EBIT High	6.38	5.91	5.69	10.87	13.24	14.15	16.38	15.61	16.3	17.08	21.25	19.96	17.34	19.73	32.01
EV/EBIT Low	4.54	5.42	5.35	5.14	10.67	9.82	11.49	12.29	10.71	9.63	13.85	15.95	14.28	14.29	14.55
Last Price	41.82	42.65	44.53	102.48	121.06	161.49	223.95	194.25	298.89	347.76	505.52	529.78	527.04	505.07	329.53
High Price	49.86	43.42	44.54	105.18	129.35	166.43	232.31	250.51	302.36	371.15	509.09	561.72	555.91	629.04	602.11
Enterprise Value Average	47,287	52,722	53,100	82,314	133,685	153,157	203,983	227,528	231,644	316,668	409,514	518,725	508,782	550,296	407,948
Enterprise Value High	54,009	54,719	54,764	111,640	145,945	182,900	249,062	270,711	320,876	382,704	509,416	567,480	560,935	637,093	607,028
Enterprise Value Low	38,428	50,127	51,500	52,825	117,644	126,988	174,737	213,076	210,775	215,767	331,911	453,634	462,153	461,449	275,987

Shares Outstanding	1,039	1,019	988	954	953	952	969	960	948	946	941	934	924	915	906
Diluted Weighted Avg Shares	1,087	1,046	1,023	986	967	968	985	983	966	961	956	950	938	929	911
Basic Weighted Avg Shares	1,039	1,019	988	954	953	952	969	960	948	946	943	934	924	915	906
Revenue per Share	98.04	108.56	123.98	136.77	164.86	194.16	207.59	235.67	255.44	271.82	304.98	347.07	402.19	437.46	494.09
EBITDA per Share	9.23	10.37	11.13	12.32	13.34	15.74	18.01	20.6	23.63	26.74	28.71	34.08	39.32	39.77	25.75
Operating Income per Share	8.15	9.08	9.74	10.77	11.56	13.58	15.7	18.07	20.76	23.68	25.42	30.44	35.02	35.29	20.94
Basic EPS, GAAP	4.95	5.42	5.69	5.89	6.1	7.37	10.9	12.49	14.6	16.28	18.33	21.54	24.22	15.74	13.31
Basic EPS from Cont Ops	4.95	5.42	5.74	5.89	6.16	7.43	11.17	12.9	15.02	16.67	18.8	22.1	25.05	16.66	14.14
Diluted EPS, GAAP	4.73	5.28	5.5	5.7	6.01	7.25	10.72	12.19	14.33	16.03	18.08	21.18	23.86	15.51	13.23
Diluted EPS from Cont Ops	4.73	5.28	5.55	5.7	6.07	7.31	10.99	12.6	14.74	16.41	18.55	21.73	24.67	16.41	14.06
Dividend per Share	0.63	0.8	1.07	1.43	1.87	2.38	2.86	3.46	4.15	4.85	5.6	6.41	7.32	8.23	8.74
Cash Flow per Share	6.71	7.02	7.08	8.44	10.22	10.29	14.03	16.37	19.48	23.44	23.69	28.06	31.46	26.45	21.74
Free Cash Flow per Basic Share	5.68	5.97	5.75	6.84	8.59	8.5	11.94	14.22	17.29	21.27	21.09	25.06	27.79	22.63	17.75
Cash & Equivalents per Share	11.56	11.22	9.32	9.68	13.55	13.94	15.99	14.92	15.03	20.91	25.35	29.88	32.06	31.82	31.04
Book Value per Share	26.79	30.1	33.46	35.48	38.97	43.02	50.3	58.18	64.54	73.26	81.81	92.25	103.66	104.97	105.55
Tangible Book Value per Share	1.46	-2.62	-2.15	-2.9	-18.24	-16.74	-11.38	-12.51	-14.61	-12.32	-9.93	-22.92	-21.65	-29.96	-32.32

UnitedHealth Group Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)